Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase …

…, J Pastré, A Le Borgne-Krams, T Dégot… - The Lancet …, 2022 - thelancet.com
Background The use of cyclophosphamide in patients with acute exacerbation of idiopathic
pulmonary fibrosis (IPF) is unknown. Our study was designed to evaluate the efficacy and …

Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes

…, J Cadranel, P Dieude, T Degot… - European …, 2019 - Eur Respiratory Soc
Regulator of telomere length 1 (RTEL1) mutations have been evidenced in 5–9% of familial
pulmonary fibrosis; however, the phenotype of patients with interstitial lung disease (ILD) …

Disseminated Trichosporon mycotoxinivorans, Aspergillus fumigatus, and Scedosporium apiospermum coinfection after lung and liver transplantation in a cystic …

…, B Lannes, MY Jeung, T Degot… - Journal of clinical …, 2012 - Am Soc Microbiol
Trichosporon mycotoxinivorans is a novel pathogen recently found in cystic fibrosis patients.
We report the first case of a disseminated fatal infection with T. mycotoxinivorans associated …

A new endoscopic standardized grading system for macroscopic central airway complications following lung transplantation: the MDS classification

…, L Cellerin, A Colchen, T Degot… - European Journal of …, 2014 - academic.oup.com
OBJECTIVES After lung transplant, between 9 and 13% of bronchial anastomoses develop
complications severe enough to warrant therapeutic intervention. These complications …

Increased extravascular lung water and plasma biomarkers of acute lung injury precede oxygenation impairment in primary graft dysfunction after lung transplantation

J Pottecher, AC Roche, T Dégot, O Helms… - …, 2017 - journals.lww.com
Background After lung transplantation (LT), early prediction of grade 3 pulmonary graft
dysfunction (PGD) remains a research gap for clinicians. We hypothesized that it could be …

[HTML][HTML] Management of patients with pulmonary mycobacteriosis in France: a multicenter retrospective cohort study

…, G Couetdic, F Couturaud, JC Dalphin, T Degot… - BMC Pulmonary …, 2021 - Springer
Background Recent studies report very low adherence of practitioners to ATS/IDSA
recommendations for the treatment of nontuberculous mycobacteria pulmonary disease (NTM-PD), …

Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosis

E Moncomble, G Weisenburger, C Picard, T Dégot… - …, 2024 - Wiley Online Library
Background Antifibrotic agents (AFAs) are now standard‐of‐care for idiopathic pulmonary
fibrosis (IPF). Concerns have arisen about the safety of these drugs in patients undergoing …

Initiation of extracorporeal photopheresis in lung transplant patients with mild to moderate refractory BOS: A single-center real-life experience

…, S Hirschi, A Essaydi, A Bohbot, T Degot… - … Medicine and Research, 2022 - Elsevier
Background Bronchiolitis obliterans syndrome (BOS) is the main limitation to long-term survival
following lung transplantation. Several studies generated promising results regarding the …

Outcome of lung transplantation for adults with interstitial lung disease associated with genetic disorders of the surfactant system

…, B Coiffard, A Roux, S Hirschi, T Degot… - ERJ Open …, 2023 - Eur Respiratory Soc
Background Interstitial lung disease associated with genetic disorders of the surfactant
system is a rare entity in adults that can lead to lung transplantation. Our objective was to …

[HTML][HTML] Factors associated with coinfections in invasive aspergillosis: a retrospective cohort study

…, K Bilger, MP Chenard, O Collange, T Degot… - Clinical Microbiology …, 2021 - Elsevier
Objectives To describe the coinfections in invasive aspergillosis (IA), to identify factors
associated with coinfections, and to evaluate the impact of coinfection on mortality. Patients and …